Searched for
ZYDUS LIFESCIENCES HEALTH CANADA APPROVAL
‘Don’t need study, we need action’: Durbin BLASTS NIH Chief over flavoured vape peddling from China26 May, 2026, 10.45 PM IST- Stock Radar:Buy Zydus Lifesciences for a target of Rs 435 in next 3-4 weeks, says Gaurav Bissa16 Aug, 2022, 08.58 AM IST
- Fundamental Radar: Zydus Lifesciences is a tactical buy for a 12-month target of Rs 572, says Unnati Jadhav29 Mar, 2023, 10.00 AM IST
- Covid-19: Canada health regulator approves Pfizer's vaccine10 Dec, 2020, 09.57 AM IST
- Stocks in focus: Ashok Leyland, HPCL, Zydus Lifesciences and more20 May, 2022, 08.09 AM IST
- Fundamental Radar I Zydus poised for growth on expansive product portfolio, R&D strength: Girish Sodani26 Aug, 2023, 04.10 PM IST
- Nectar Lifesciences earns European cGMP approvalET31.jpg12 Dec, 2011, 02.44 PM IST
- Corner Office Conversation with The New Leaders of Indian Pharma04 Aug, 2025, 07.00 AM IST
- LIVE| Alberta Premier Danielle Smith unveils major shakeup in health funding08 Apr, 2025, 12.08 AM IST
- India approves Zydus Cadila's DNA based COVID-19 vaccine for emergency use20 Aug, 2021, 08.04 PM IST
- Covaxin gets WHO approval for emergency use03 Nov, 2021, 05.41 PM IST
- WHO's approval for emergency use of Covaxin likely this month13 Sep, 2021, 09.08 PM IST
- COVID-19 vaccine: Zydus Cadila seeks emergency use approval of 'ZyCoV-D' for 12 years and above01 Jul, 2021, 09.43 AM IST
- About 50 countries show interest for CoWIN platform, PM Modi to address Global Conclave today05 Jul, 2021, 08.21 AM IST
- Cabinet approves ordinance to protect health workers under attack during covid-19 pandemic22 Apr, 2020, 04.22 PM IST
- After 50% tariff and H1B restrictions, Trump puts 100% duty on branded pharma: Indian stocks tumble26 Sep, 2025, 10.59 AM IST
- Cabinet approves Rs 5 lakh health cover for senior citizens above 70 under Ayushman Bharat Scheme11 Sep, 2024, 09.25 PM IST
- Karnataka Dy CM DK Shivakumar on COVID-19 subcommittee meet, says 'We don't want to witch hunt…07 Dec, 2024, 05.43 PM IST
Load More
